# Altimmune UK (Altimmune UK Limited) Private limited company registered in Leeds, classed under “Research and experimental development on biotechnology”. - Company number: 02753142 - Status: Active - Type: Private limited company - Incorporated: 5 October 1992 - Registered office: Central Square 5th Floor, 29 Wellington Street, Leeds, LS1 4DL - Location: Leeds - Activity: Research and experimental development on biotechnology ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Altimmune UK do? Private limited company registered in Leeds, classed under “Research and experimental development on biotechnology”. ### How much turnover does Altimmune UK make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/altimmune-uk-02753142 ### Is Altimmune UK profitable? We haven't found a profit figure in Altimmune UK's latest filed accounts. ### How many people work at Altimmune UK? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/altimmune-uk-02753142 ### Who runs and owns Altimmune UK? Its directors are Gregory Lee Weaver, Altimmune, Inc.. Its owners are shown to subscribers. ### Where is Altimmune UK based? Its registered office is Central Square 5th Floor, 29 Wellington Street, Leeds, LS1 4DL, in Leeds. ### When was Altimmune UK founded? Altimmune UK Limited was incorporated on 5 October 1992. ### Is Altimmune UK still trading? The register lists Altimmune UK Limited as active. ## Timeline Recent filings and changes at Companies House. - 2026-07-29: Appointment of Gregory Lee Weaver as a director on 24 July 2026 - 2026-06-04: Cessation of Vipin Garg as a person with significant control on 4 June 2026 - 2026-06-04: Termination of appointment of Vipin Garg as a director on 4 June 2026 - 2026-06-04: Appointment of Altimmune, Inc. as a director on 4 June 2026 - 2025-10-09: Amended accounts for a small company made up to 31 December 2024 - 2025-09-30: Total exemption full accounts made up to 31 December 2024 - 2024-10-18: Amended accounts for a small company made up to 31 December 2023 - 2024-10-01: Total exemption full accounts made up to 31 December 2023 - 2023-08-04: Accounts for a small company made up to 31 December 2022 - 2023-05-31: Director's details changed for President Vipin Garg on 30 May 2023 - 2023-05-31: Change of details for President Vipin Garg as a person with significant control on 30 May 2023 - 2022-08-25: Accounts for a small company made up to 31 December 2021 - 2022-08-15: Second filing for the notification of Vipin Garg as a person with significant control - 2022-06-07: Second filing for the appointment of President Vipin Garg as a director (and 1 more like it since 17 May 2022) - 2021-09-20: Accounts for a small company made up to 31 December 2020 - 2021-05-17: Notification of Altimmune, Inc. as a person with significant control on 13 May 2021 - 2020-12-17: Group of companies' accounts made up to 31 December 2019 - 2019-09-27: Group of companies' accounts made up to 31 December 2018 - 2019-04-15: Notification of Vipin Garg as a person with significant control on 30 November 2018 - 2019-04-15: Appointment of Vipin Garg as a director on 30 November 2018 - 2019-04-11: Cessation of William James Enright as a person with significant control on 30 November 2018 - 2019-04-11: Termination of appointment of William James Enright as a director on 30 November 2018 - 2018-12-19: Registered office address changed from London Bioscience Innovation Centre, 2 Royal College Street London NW1 0NH to Central Square 5th Floor 29 Wellington Street Leeds LS1 4DL … - 2018-06-21: Group of companies' accounts made up to 31 December 2017 - 2018-05-22: Termination of appointment of Elizabeth Adkins Czerepak as a director on 8 May 2018 --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/altimmune-uk-02753142